Our results indicated that breast cancer patients with later pathological stages, more lymph node metastasis, negative hormone receptor expression, and positive HER2 expression tended to have a higher percentage of risk to develop secondary diabetes and IFG. The gene discussed is ERBB2; the disease is metastatic malignant neoplasm in the lymph nodes.